The pathogenesis of Leishmania/HIV co-infection: Cellular and immunological mechanisms

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue SUPPL. 1, 2003, Pages

  Olivier, M ^a   Badaro R ^b   Medrano, F J ^c   Moreno, J ^d  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW CELL; CELLULAR IMMUNITY; CYTOKINE RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IN VITRO STUDY; INFECTION RISK; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHOID CELL; LYMPHOID ORGAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SOUTHERN EUROPE; SUPERINFECTION; TH1 CELL; TH2 CELL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIA DONOVANI; PROTOZOA; RNA VIRUSES;

EID: 0345257737     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803225002561     Document Type: Review

References (90)

1. Abel, P. M., McSharry, C., Galloway, E., Ross, C., Severn, A., Toner, G., Gruer, L. & Wilkinson, P. C. (1992). Heterogeneity of peripheral blood monocyte populations in human immunodeficiency virus-1 seropositive patients. FEMS Microbiology and Immunology, 5, 317-323.
2. Alvar, J. (1994). Leishmaniasis and AIDS co-infection: the Spanish example. Parasitology Today, 10, 160-163.
3. Alvar, J., Verdejo, J., Osuna, A. & Nájera, R. (1987). Visceral leishmaniasis in a patient seropositive for HIV. European Journal of Clinical Microbiology, 6, 604-606.
4. Aukrust, P., Liabakk, N. B., Muller, F., Lien, E., Espevik, T. & Froland, S. S. (1994). Serum levels of tumor necrosis factor-alpha (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologie parameters. Journal of Infectious Diseases, 169, 420-424.
5. Badaró, R. (1997). When Leishmania and HIV interact, a new broad spectrum of leishmaniasis occurs. British Journal of Infectious Diseases, 1, 145-148.
6. Badaró, R., Carvalho, E. M., Rocha, H., Queiroz, A. C. & Jones, T. C. (1986a). Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet, i, 647-649.
7. Badaró, R., Jones, T. C., Carvalho, E. M., Sampaio, D., Reed, S. G., Barral, A., Teixeira, R. & Johnson Jr, W. D. (1986b). New perspectives on a subclinical form of visceral leishmaniasis. Journal of Infectious Diseases, 154, 1003-1011.
8. Barbeau, B., Bernier, R., Dumais, N., Briand, G., Olivier, M., Faure, R., Posner, B. I. & Tremblay, M. (1997). Activation of HIV-1 LTR transcription and virus replication via NF-κB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. Journal of Biological Chemistry, 272, 12,968-12,977.
9. Barral, A., Barral-Netto, M., Yong, E. C., Brownell, C. E., Twardzik, D. R. & Reed, S. G. (1993). Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proceedings of the National Academy of Sciences of the United States of America, 90, 3442-3446.
10. Barral-Netto, M., Badaró, R., Pedral-Sampaio, D., Carvalho, E. M., Falcoff, E. & Falcoff, R. (1991). Tumor necrosis factor (cachectin) in human visceral leishmaniasis. Journal of Infectious Diseases, 163, 853-857.
11. Barral-Netto, M., Machado, P. & Barral, A. (1995). Human cutaneous leishmaniasis: recent advances in physiopathology and treatment. European Journal of Dermatology, 5, 104-113.
12. Bernier, R., Turco, S. J., Olivier, M. & Tremblay, M. J. (1995). Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. Journal of Virology, 69, 7282-7285.
13. Bernier, R., Barbeau, B., Tremblay, M. J. & Olivier, M. (1998). The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappa B elements. Journal of Immunology, 160, 2881-2888.
14. Biggar, R. J., Goedert, J. J. & Hoofnagle, J. (1987). Accelerated loss of antibody to hepatitis B surface antigens among immunodeficient homosexual men infected with HIV. New England Journal of Medicine, 316, 630-631.
15. Borthwick, N. J., Bofill, M., Gombert, W. M., Akbar, A. N., Medina, E., Sagawa, K., Lipman, M. C., Johnson, M. A. & Janossy, G. (1994). Lymphocyte activation in HIV-infection. Functional defects of CD28-T cells. AIDS, 8, 431-441.
16. Cacopardo, B., Nigro, L., Preiser, W., Fama, A., Satariano, M. I., Braner, J., Celesia, B. M., Weber, B., Russo, R. & Doerr, H. W. (1996). Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Transactions of the Royal Society and Tropical Medicine and Hygiene, 90, 434-435.
17. Carvalho, E. M., Teixeira, R. S. & Johnson Jr, W. D. (1981). Cell mediated immunity in American visceral leishmaniasis: reversible immunosupression during acute infection. Infection and Immunity, 33, 498-502.
18. Cenini, P., Berhe, N., Hailu, A., McGinnes, K. & Frommel, D. (1993). Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. Journal of Infectious Diseases, 168, 986-993.
19. Cenini, P., Berhe, N., Hailu, A. & Frommel, D. (1994). Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis. Journal of Infectious Diseases, 169, 707-708.
20. Chamot, E., Hirschel, B., Wintsch, J., Robert, C. F., Gabriel, V., Deglon, J. J., Yerly, S. & Perrin, L. (1990). Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS, 4, 1275-1277.
21. Chehimi, J., Starr, S. E., Frank, I., d'Andrea, A., Ma, X., MacGregor, R. R., Sennelier, J. & Trinchieri, G. (1994). Impaired interleukin 12 production in human immunodeficiency virus-infected patients. Journal of Experimental Medicine, 179, 1361-1366.
22. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. D., Lucey, D. R., Via, C. S. & Shearer, G. M. (1989). Detection of three distinct patterns of T helper cell dysfunction in asymptomatic HIV-seropositive patients. Journal of Clinical Investigation, 84, 1892-1899.
23. Clerici, M., Hakim, F. T. D., Venzon, D. J., Blatt, S., Hendrix, C. W., Wynn, T. A. & Shearer, G. M. (1993). Changes in interleukin 2 and interleukin 4 in asymptomatic human immunodeficiency virus-seropositive individuals. Journal of Clinical Investigation, 91, 759-765.
24. Coutinho, S. G., Da-Cruz, A. M., Pereira de Oliveira, M., Mendonca, S. C. F., Bertho, A. L. & de Luca, P. M. (1996). CD4+ and CD8+ T cell immune response of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis. Memórias do Institudo Oswaldo Cruz, 91, 381-384.
25. Da-Cruz, A. M., Conceiçao-Silva, F., Bertho, A. L. & Coutinho, S. G. (1994). Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infection and Immunity, 62, 2614-2618.
26. Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F. & Weiss, R. A. (1984). The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, 312, 763-767.
27. De Martini, R. M., Turner, R. R., Formenti, S. C., Boone, D. C., Bishop, P. C., Levine, A. M. & Parker, J. W. (1988). Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection. Clinical Immunology and Immunopathology, 46, 258-271.
28. De Souza, E., Souza, I., Naiff, R. D., Guimarães, T. C., Naiff, M. F., Cupolillo, E., Rodrigues, W. A. & Schettini, A. P. (1998). American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. Journal of the European Academy of Dermatology and Venereology, 10, 214-217.
29. Desjeux, P. & Alvar, J. (2003). Leishmania/HIV co-infections: epidemiology in Europe. Annals of Tropical Medicine and Parasitology, 97 (Suppl.), 3-15.
30. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S. & Rabson, A. B. (1989). Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proceeding of the National Academy of Sciences of the United States of America, 86, 5974-5978.
31. Dumais, N., Barbeau, B., Olivier, M. & Tremblay, M. (1998). Prostaglandin E2 upregulates HIV-1 LTR-driven gene activity in T cells via NF-κ-dependent and -independent signaling pathways. Journal of Biological Chemistry, 273, 27,306-27,314.
32. Easterbrook, M. D., Levy, M. H., Gomez, K. M., Turco, S. J., Epand, R. M. & Rosenthal K. L. (1995). Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. Journal of AIDS and Human Retrovirology, 10, 496-505.
33. Fauci, A. S. (1988a). The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science, 239, 617-622.
34. Fauci, A. S. (1988b). Immunopathogenic mechanisms of human immunodeficiency virus (HIV) infection. In Human Retroviruses, Cancer, and AIDS: Approaches to Prevention and Therapy, ed. Bolegnesi, D. p. 187. New York: Alan R. Liss.
35. Fauci, A. S. (1996). Host factors and the pathogenesis of HIV-induced disease. Nature, 384, 529-534.
36. Fillola, G., Corberand, J. X., Laharrague, P. F., Levenes, H., Massip, P. & Recco, P. (1992). Peripheral intramonocytic leishmaniasis in an AIDS patient. Journal of Clinical Microbiology, 30, 3284-3285.
37. Foley, P., Kazazi, F., Biti, R., Sorrell, T. C. & Cunningham, A. L. (1992). HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology, 75, 391-397.
38. Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A. & Fauci, A. S. (1987). Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science, 238, 800-802.
39. Frank, Y., Pavlakis, S., Black, K. & Bakshi, S. (1998). Reversible occipital-parietal encephalopathy syndrome in an HIV-infected child. Neurology, 51, 915-916.
40. Frantz, B., Nordby, E., Bren, G., Steffan, N., Paya, C., Kincaid, R., Tocci, M. J., O'Keefe, S. J. & O'Neill, E. A. (1994). Calcineurin acts in synergy with PMA to inactivate IκB/MAD-3 an inhibitor of NF-κB. EMBO Journal, 13, 861-870.
41. Gazzinelli, R. T., Bala, S., Stevens, R., Baseler, M., Wahl, L., Kovacs, J. & Sher, A. (1995). HIV infection supresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. Journal of Immunology, 155, 1565-1574.
42. Gradoni, L. & Gramiccia, M. (1994). Leishmania infantum tropism: strain genotype or host immune status? Parasitology Today, 10, 264-267.
43. Graziosi, C., Pantaleo, G., Gantt, K. R., Fortin, J. P., Demarest, J. F., Cohen, O. J., Sekaly, R. P. & Fauci, A. S. (1994). Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science, 265, 248-252.
44. Haldar, J. P., Ghose, S., Saha, K. C. & Ghose, A. C. (1983). Cell-mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis. Infection and Immunity, 42, 702-707.
45. Handman, E., Schnur, L. F., Spithill, T. W. & Mitchell, G. H. (1986). Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages. Journal of Immunology, 137, 3608-3613.
46. Haug, C. H. J., Aukrust, P., Lien, E., Miller, F., Espevik, T. & Froland, S. S. (1996). Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. Journal of Infectious Diseases, 173, 259-262.
47. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123-126.
48. Janossy, G., Borthwick, N., Lomnitzer, R., Medina, E., Squire, S. B., Phillips, A. N., Lipman, M., Johnson, M. A., Lee, C. & Bofill, M. (1993). Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages. AIDS, 7, 613-624.
49. Jeannel, D., Tuppin, P., Bruckler, G., Danis, M. & Gentilini, M. (1989). Leishmaniasis in France. Lancet, ii, 804.
50. Jeronimo, S. M., Oliveira, R. M., Mackay, S., Costa, R. M., Sweet, J., Nacimiento, E. T., Luz, K. G., Fernández, M. Z., Jernigan, J. & Pearson, R. D. (1994). An urban outbreak of visceral leishmaniasis in Natal, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 386-388.
51. Jiménez, M. I., Gutierrez-Solar, B., Benito, A., Aguiar, A., García, E., Cercenado, E. & Alvar, J. (1991). Cutaneous Leishmania infantum zymodemes isolated from bone marrow in AIDS patients. Research and Reviews in Parasitology, 51, 95-99.
52. Jiménez, M. I., López-Vélez, R., Molina, R., Cavañate, C. & Alvar, J. (1996). HIV coinfection with a currently non-pathogenic flagellate. Lancet, i, 264-265.
53. Kekow, J., Wachsman, W., McCutchan, J. A., Cronin, M., Carson, D. A. & Lotz, M. (1990). Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proceedings of the National Academy of Sciences of the United States of America, 87, 8321-8325.
54. Kemp, M., Kurtzhals, J. A. L., Bendtzen, K., Poulsen, L. K., Hansen, M. B., Koech, D. K., Kharazmi, A. & Theander, T. G. (1993). Leishmania donovani-reactive Th1-and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infection and Immunity, 61, 1069-1073.
55. Kemp, M., Hey, A, S., Kurtzhals, J. A., Christensen, C. B., Gaafar, A., Mustafa, M.D., Kordonafi, A. A., Ismail, A., Kharazmi, A. & Theander, T. G. (1994). Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigotes antigens in individuals recovered from cutaneous leishmaniasis. Clinical and Experimental Immunology, 96, 410-415.
56. Klatzmann, D., Barré-Sinoussi, F., Nugeyre, M. T., Dauguet, C., Vilmer, E., Griscelli, C., Brun-Veziret, F-. Rouzioux, C., Gluckman, J. C., Chermann, J. C. & Montagnier, L. (1984). Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science, 225, 59-63.
57. Klein, S. A., Dobmeyer, J. M., Dobmeyer, T. S., Pape, M., Ottmann, O. G., Helm, E. B., Hoelzer, D. & Rossol, R. (1997). Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS, 11, 1111-1118.
58. Kubar, J., Marty, P., Lelievre, A., Quaranta, J. F., Staccini, P., Caroli-Bosc, C. & Le Fichoux, Y. (1998). Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS, 12, 2147-2153.
59. Levy, J. A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiology Reviews, 57, 183-289.
60. Lewis, R. S. & Cahalan, M. D. (1995). Potassium and calcium channels in lymphocytes. Annual Review of Immunology, 13, 623-653.
61. Liew, F. Y. & O'Donnell, C. A. (1993). Immunology of leishmaniasis. Advances in Parasitology, 32, 161-259.
62. Maggi, E., Mazzetti, M., Ravina, A., Annunziato, F., de Carli, M., Piccini, M. P., Manetti, R., Carbonari, M., Pesce, A. M., del Prete, G. & Romagnani, S. (1994). Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science, 265, 244-248.
63. Mansfield, J. M. & Olivier, M. (2002). Immune evasion by parasites. In Immunology of Infectious Diseases, eds Kaufmann, S. H. E., Sher, A. & Ahmed, R. pp. 379-392. Washington, DC: American Society for Microbiology.
64. Martínez, P., de la Vega, E., Laguna, F., Soriano, V., Puente, S., Moreno, V., Sentchordi, M. J., Garcia-Aguado, C. & Gonzȧlez-Lahoz, J. (1993). Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS, 7, 227-230.
65. Marty, P., Le Fichoux, Y., Pratlong, F. & Gari-Toussaint, M. (1994). Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 33-34.
66. Mary, C., Lamouroux, D., Dunan, S. & Quilici, M. (1992). Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. American Journal of Tropical Medicine and Hygiene, 47, 764-771.
67. Matte, C., Maion, G., Mourad, W. & Olivier, M. (2001). Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis. Parasite Immunology, 23, 177-184.
68. McDougal, J. S., Nicholson, J. K. A., Cross, G. D., Cort, S. P., Kennedy, M. S. & Mawle, A. C. (1986). Binding of the human retrovirus HTLV-III/LAV/ ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology, 137, 2937-2944.
69. Medrano, F. J., Hernández-Quero, J., Jiménez, E., Pineda, J. A., Rivero, A., Sanchez-Quijano, A., Vélez, I. D., Viciana, P., Castillo, R., Reyes, M. J., Carvajal, F., Leal, M. & Lissen, E. (1992). Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS, 6, 1499-1503.
70. Medrano, F. J., Leal, M., Arienti, D., Rey, C., Zagliani, A., Torres, Y., Sánchez-Quijano, Lissen, E. & Clerici, M. (1998a). Tumor necrosis factor β and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients. AIDS Research and Human Retrovirology, 14, 833-844.
71. Medrano, F. J., Rey, C., Leal, M., Cañavate, C., Rubio, A., Sánchez-Quijano, A., Alvar, J. & Lissen, E. (1998b). Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clinical and Experimental Immunology, 114, 733-737.
72. Melbye, M., Biggar, R. J., Ebbesen, P., Nealand, C., Goedert, J. J., Faber, V., Lorenzen, I., Skinhoj, P., Gallo, R. C. & Blattner, W. A. (1986). Longterm seropositivity for HTLV-III in homosexual men without the acquired immunodeficiency syndrome: development of immunological and clinical abnormalities: a longitudinal study. Annals of Internal Medicine, 104, 496-500.
73. Mellors, J. W., Griffith, B. P., Ortiz, M. A., Landry, M. L. & Ryan, J. L. (1991). Tumor necrosis factor alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. Journal of Infectious Diseases, 163, 78-82.
74. Mellors, J. W., Rinaldo, C., Gupta, P., White, R. M., Todd, J. A. & Kingsley, L. A. (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science, 272, 1167-1170.
75. Mellors, J. W., Muñoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Detels, R., Phair, J. P. & Rinaldo Jr, C. R. (1997). Plasma viral load and CD4+ lymphocytes as prognostic morkers of HIV-1 infection. Annals of Internal Medicine, 126, 946-954.
76. Meltzer, M. S., Skillman, D. R., Gomatos, P. J., Kalter, D. C. & Gendelman, H. E. (1990). Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annual Review of Immunology, 8, 169-194.
77. Miralles, G. D., Stoeckle, M. Y., McDermott, D. F., Finkelman, F. D. & Murray, H. W. (1994). Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infection and Immunity, 62, 1058-1063
78. Moreno-Camacho, A., López-Vélez, R., Muñoz Sanz, A. & Labarga-Echevarria, P. (1998). Intestinal parasitic infections and leishmaniasis in patients with HIV infection. Enfermedades Infecciosas y Microbiologia Clinica, 16 (Suppl. 1), 52-60.
79. Morrow, R. H., Colebunders, R. L. & Chin, J. (1989). Interactions of HIV infection with endemic tropical diseases. AIDS, 3 (Suppl. 1), S79-S87.
80. Muñoz-Rodríguez, F. J., Padro, S., Pastor, P., Rosa-Re, D., Valls, M. E., Miro, J. M. & Gatell, M. (1997). Pleural and peritoneal leishmaniasis in an AIDS patient. European Journal of Clinical Microbiology and Infectious Diseases, 16, 246-248.
81. Murray, H. W., Oca, M. J., Granger, A. M. & Schreiber, R. D. (1989). Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. Journal of Clinical Investigation, 83, 1253-1257.
82. Murray, H. W., Squires, K. E., Miralles, C. D., Stoeckle, M. Y., Granger, A. M., Granelli-Piperno, A., Bogdan, C. (1992). Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. Journal of Immunology, 148, 1858-1863.
83. Nabors, G. S. & Farrell, J. P. (1996). Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. Journal of Infectious Diseases, 173, 979-986.
84. Nigro, L., Cacopardo, B., Preiser, W., Braner, J., Cinatl, J., Palermo, F., Russo, R., Doerr, H. W. & Nunnari, A. (1999). In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum. American Journal of Tropical Medicine and Hygiene, 60, 142-145.
85. 2+. Parasitology Today, 12, 145-150.
86. Olivier, M., Baimbridge, K. G. & Reiner, N. E. (1992a). Inhibition of N-formyl-methionyl-leucyl-phenylalanine-induced stimulus-response coupling in monocytes infected with Leishmania: evidence for a defect in agonist-induced calcium release. Journal of Immunology, 148, 1188-1196.
87. Olivier, M., Brownsey, R. W. & Reiner, N. E. (1992b). Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation of protein kinase C. Proceedings of the National Academy of Sciences of the United States of America, 89, 7481-7485.
88. Olivier, M., Romero-Gallo, B. J., Matte, C., Blanchette, J., Posner, B. I., Tremblay, M. & Faure, R. (1998). Modulation of interferon-γ- induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine leishmaniasis progression. Journal of Biological Chemistry, 273, 13,944-13,949.
89. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orestein, J. M., Kotler, D. P. & Fauci, A. S. (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature, 362, 355-358.
90. Pantaleo, G., Graziosi, C., Demarest, J. F., Cohen, O. J., Vaccarezza, M., Gantt, K., Muro Cacho, C. & Fauci, A. S. (1994). Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunology Reviews, 140, 105-130.